Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Looking for ways to monetize skills quickly? Turn your talents into cash and start earning today with these strategies.
17,417 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
David Tepper accelerates a $400 million macro bet pairing a country ETF with a memory-chip giant, underscoring what s...
A fresh look at why a trillion-dollar cloud leader could outpace Apple in AI. Learn the mechanics, risks, and how to ...
A personal investing journey shows why AMD stock remains my priority over Nvidia. Learn how valuation, product synerg...
GPIQ has drawn billions with a near-10% yield by selling call options on mega-cap tech. The strategy injects income b...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
Joby Aviation shares hover near $9 as certification hurdles and a new funding round set the stage for a possible upsi...
CoreWeave tumbled in morning trading as a legal case, insider sales and high leverage raise questions about its path ...
Palantir stock is shaping up for a year-end move as AI demand and expanding government and commercial contracts fuel ...
A practical look at a top energy stock evolving at the crossroads of renewables and AI. Learn how to assess the setup...
SpaceX wiped out most of its early IPO surge as trading shifted toward a new Nasdaq-100 opening. The stock is testing...
Greg Abel, stepping into Warren Buffett's shoes, is quietly steering Berkshire Hathaway toward tech-driven bets. A bi...